関連する実験動画
Updated: Feb 20, 2026

04:48
Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
11.7K
食事行動が,頭蓋骨腫に関連する肥満に与える影響
Danielle Eddy1, Rebecca L Elsworth2,3, Toby Philip Candler1,2
1Bristol Royal Hospital for Children, University Hospitals Bristol and Weston Foundation Trust, Bristol, UK.
Journal of pediatric endocrinology & metabolism : JPEM
|February 18, 2026
まとめ
クラニオファリンギョーマに関連した肥満は,過食性食生活と関連している可能性があります. 検証された評価を用いたさらなる研究は,これらの食行動を理解し,頭蓋骨腫患者のための標的型介入を開発するために必要です.
科学分野:
- 神経科学は神経科学である.
- エンドクリノロジー エンドクリノロジー
- 腫瘍学 腫瘍学
背景:
- クラニオファリンギオマは,下垂体と下垂体機能障害と肥満に関連した細胞上の腫瘍です.
- クラニオファリンギョーマに関連した肥満における食事行動の役割を理解することは,患者のケアにとって極めて重要です.
研究 の 目的:
- クラニオファリンギョーマに関連した肥満に,過食性食生活と食欲要因の影響を調査する.
- 食事行動をターゲットとした将来の介入のための潜在的な分野を特定する.
主な方法:
- PRISMA-ScRとJBIの方法論に従ったスコーピングレビュー.
- 5つのデータベースと2つの臨床試験のレジストリで,食生活に関するクランニオファリンギョーマ患者の研究を検索しました.
- 幼児期または成人期発症の頭蓋骨腫に関する研究では,介入,神経イメージング,内分泌反応などのさまざまな関連要因が含まれています.
主要な成果:
- クラニオファリンギョーマ患者の食生活に関する証拠は限られており,検証された評価を用いた研究はほとんどありません.
- 食事の行動は,しばしば二次的な結果であったり,正式な測定なしに言及されたりしました.
- 成人発症の頭蓋骨腫に焦点を当てた研究はほとんどなく,肥満患者と肥満でない患者を比較した研究はほとんどなく,介入研究は見つかりませんでした.
結論:
- クラニオファリンギョーマに関連した肥満のメカニズムを理解するために,検証された測定値を用いたさらなる研究が必要である.
- 食事の行動に関する理解の向上は,クリニカル・プラクティスや,クラーニオファリンギョーマ患者の患者中心のケアに役立つ.
関連する概念動画
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Regulation of Food Intake
2.9K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.9K
Bulimia Nervosa
837
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
837
Binge Eating Disorders
538
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
538
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
302
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
208
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
208

